• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肠病的病程是否可预测?

Is the disease course predictable in inflammatory bowel diseases?

机构信息

1st Department of Medicine, Semmelweis University, H-1083 Budapest, Koranyi S 2A, Hungary.

出版信息

World J Gastroenterol. 2010 Jun 7;16(21):2591-9. doi: 10.3748/wjg.v16.i21.2591.

DOI:10.3748/wjg.v16.i21.2591
PMID:20518079
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2880770/
Abstract

During the course of the disease, most patients with Crohn's disease (CD) may eventually develop a stricturing or a perforating complication, and a significant number of patients with both CD and ulcerative colitis will undergo surgery. In recent years, research has focused on the determination of factors important in the prediction of disease course in inflammatory bowel diseases to improve stratification of patients, identify individual patient profiles, including clinical, laboratory and molecular markers, which hopefully will allow physicians to choose the most appropriate management in terms of therapy and intensity of follow-up. This review summarizes the available evidence on clinical, endoscopic variables and biomarkers in the prediction of short and long-term outcome in patients with inflammatory bowel diseases.

摘要

在疾病过程中,大多数克罗恩病(CD)患者最终可能会出现狭窄或穿孔并发症,而且相当数量的 CD 和溃疡性结肠炎患者将需要手术。近年来,研究的重点是确定炎症性肠病疾病过程预测中重要因素,以改善患者分层,确定包括临床、实验室和分子标志物在内的个体患者特征,这有望使医生能够根据治疗和随访强度选择最合适的管理方案。这篇综述总结了目前关于炎症性肠病患者短期和长期结局预测的临床、内镜变量和生物标志物的可用证据。

相似文献

1
Is the disease course predictable in inflammatory bowel diseases?炎症性肠病的病程是否可预测?
World J Gastroenterol. 2010 Jun 7;16(21):2591-9. doi: 10.3748/wjg.v16.i21.2591.
2
Prediction of disease course in inflammatory bowel diseases.炎症性肠病病程预测。
World J Gastroenterol. 2010 Jun 7;16(21):2589-90. doi: 10.3748/wjg.v16.i21.2589.
3
[Prediction of the disease course in inflammatory bowel diseases].[炎症性肠病疾病进程的预测]
Orv Hetil. 2010 Feb 21;151(8):293-301. doi: 10.1556/OH.2010.28813.
4
Role of endoscopy in predicting the disease course in inflammatory bowel disease.内镜在预测炎症性肠病病程中的作用。
World J Gastroenterol. 2010 Jun 7;16(21):2626-32. doi: 10.3748/wjg.v16.i21.2626.
5
Inflammatory bowel disease in children--clinical, endoscopic, radiologic and histopathologic investigation.儿童炎症性肠病——临床、内镜、放射学及组织病理学调查
J Korean Med Sci. 1992 Sep;7(3):221-35. doi: 10.3346/jkms.1992.7.3.221.
6
Role of genetics in prediction of disease course and response to therapy.遗传学在预测疾病进程和治疗反应中的作用。
World J Gastroenterol. 2010 Jun 7;16(21):2609-15. doi: 10.3748/wjg.v16.i21.2609.
7
Diagnostic problems and advances in inflammatory bowel disease.炎症性肠病的诊断问题与进展
Mod Pathol. 2003 Apr;16(4):347-58. doi: 10.1097/01.MP.0000064746.82024.D1.
8
Do clinical factors help to predict disease course in inflammatory bowel disease?临床因素有助于预测炎症性肠病的疾病进程吗?
World J Gastroenterol. 2010 Jun 7;16(21):2600-3. doi: 10.3748/wjg.v16.i21.2600.
9
Serologic and laboratory markers in prediction of the disease course in inflammatory bowel disease.炎症性肠病病程预测的血清学和实验室标志物。
World J Gastroenterol. 2010 Jun 7;16(21):2604-8. doi: 10.3748/wjg.v16.i21.2604.
10
Severe inflammatory bowel disease: medical management.重症炎症性肠病:药物治疗
Dig Dis. 2003;21(1):46-53. doi: 10.1159/000071339.

引用本文的文献

1
Colonic Epithelial Circadian Disruption Worsens Dextran Sulfate Sodium-Induced Colitis.结肠上皮生物钟紊乱加重葡聚糖硫酸钠诱导的结肠炎。
Inflamm Bowel Dis. 2023 Mar 1;29(3):444-457. doi: 10.1093/ibd/izac219.
2
Vitamin D Supplementation and Mental Health in Inflammatory Bowel Diseases and Irritable Bowel Syndrome Patients: A Systematic Review.维生素 D 补充与炎症性肠病和肠易激综合征患者的心理健康:系统评价。
Nutrients. 2021 Oct 19;13(10):3662. doi: 10.3390/nu13103662.
3
Analysis of Association Between Dietary Intake and Red Blood Cell Count Results in Remission Ulcerative Colitis Individuals.分析饮食摄入与缓解期溃疡性结肠炎个体红细胞计数结果之间的关系。
Medicina (Kaunas). 2019 Apr 8;55(4):96. doi: 10.3390/medicina55040096.
4
Factors associated with the achievement of mucosal healing in Crohn's disease: the benefit of endoscopic monitoring in treating to target.克罗恩病黏膜愈合的相关因素:内镜监测在达标治疗中的益处。
Therap Adv Gastroenterol. 2017 Jun;10(6):453-463. doi: 10.1177/1756283X17698089. Epub 2017 Mar 28.
5
What is the impact of age on adult patients with inflammatory bowel disease?年龄对成年炎症性肠病患者有何影响?
Clujul Med. 2013;86(1):3-9. Epub 2013 Feb 4.
6
Endoscopy Assessment at 1-Year Identifies Long-Term Responders to Thiopurines Maintenance Therapy in Patients With Crohn's Disease.1年时的内镜评估可识别克罗恩病患者对硫嘌呤维持治疗的长期反应者。
Medicine (Baltimore). 2015 Aug;94(31):e1204. doi: 10.1097/MD.0000000000001204.
7
CD73 is critical for the resolution of murine colonic inflammation.CD73对小鼠结肠炎症的消退至关重要。
J Biomed Biotechnol. 2012;2012:260983. doi: 10.1155/2012/260983. Epub 2012 Oct 14.
8
Current status of thiopurine analogues in the treatment in Crohn's disease.硫唑嘌呤类似物在克罗恩病治疗中的应用现状。
World J Gastroenterol. 2011 Oct 21;17(39):4372-81. doi: 10.3748/wjg.v17.i39.4372.
9
Effect of childbirth on the course of Crohn's disease; results from a retrospective cohort study in the Netherlands.生育对克罗恩病病程的影响:荷兰回顾性队列研究结果。
BMC Gastroenterol. 2011 Jan 26;11:6. doi: 10.1186/1471-230X-11-6.
10
Prediction of disease course in inflammatory bowel diseases.炎症性肠病病程预测。
World J Gastroenterol. 2010 Jun 7;16(21):2589-90. doi: 10.3748/wjg.v16.i21.2589.

本文引用的文献

1
Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease.黏膜愈合可预测早期克罗恩病患者的持续临床缓解。
Gastroenterology. 2010 Feb;138(2):463-8; quiz e10-1. doi: 10.1053/j.gastro.2009.09.056. Epub 2009 Oct 8.
2
Anti-microbial antibodies in celiac disease: trick or treat?乳糜泻中的抗微生物抗体:是陷阱还是机遇?
World J Gastroenterol. 2009 Aug 21;15(31):3891-900. doi: 10.3748/wjg.15.3891.
3
Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis.预测溃疡性结肠炎患者对英夫利昔单抗反应的黏膜基因特征
Gut. 2009 Dec;58(12):1612-9. doi: 10.1136/gut.2009.178665. Epub 2009 Aug 20.
4
Association of the novel serologic anti-glycan antibodies anti-laminarin and anti-chitin with complicated Crohn's disease behavior.新型血清抗聚糖抗体抗-昆布多糖和抗几丁质与复杂克罗恩病行为的相关性。
Inflamm Bowel Dis. 2010 Feb;16(2):263-74. doi: 10.1002/ibd.21046.
5
Early azathioprine/biological therapy is associated with decreased risk for first surgery and delays time to surgery but not reoperation in both smokers and nonsmokers with Crohn's disease, while smoking decreases the risk of colectomy in ulcerative colitis.早期使用硫唑嘌呤/生物制剂治疗与克罗恩病患者(无论是否吸烟)首次手术风险降低和手术时间延迟有关,但不增加再次手术风险,而吸烟则降低溃疡性结肠炎患者结肠切除术的风险。
Eur J Gastroenterol Hepatol. 2010 Jul;22(7):872-9. doi: 10.1097/MEG.0b013e32833036d9.
6
Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biological therapy are predictors of disease behavior change in patients with Crohn's disease.肛周疾病、小肠疾病、吸烟、既往使用类固醇或早期使用硫唑嘌呤/生物治疗是克罗恩病患者疾病行为改变的预测因素。
World J Gastroenterol. 2009 Jul 28;15(28):3504-10. doi: 10.3748/wjg.15.3504.
7
Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype.与炎症性肠病诊断和表型相关的新型抗聚糖抗体。
Am J Gastroenterol. 2009 Jun;104(6):1426-34. doi: 10.1038/ajg.2009.79. Epub 2009 Apr 21.
8
The natural history of pediatric ulcerative colitis: a population-based cohort study.儿童溃疡性结肠炎的自然病史:一项基于人群的队列研究。
Am J Gastroenterol. 2009 Aug;104(8):2080-8. doi: 10.1038/ajg.2009.177. Epub 2009 May 12.
9
Genetic risk profiling and prediction of disease course in Crohn's disease patients.克罗恩病患者的遗传风险分析及疾病进程预测
Clin Gastroenterol Hepatol. 2009 Sep;7(9):972-980.e2. doi: 10.1016/j.cgh.2009.05.001. Epub 2009 May 5.
10
Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease.黏膜愈合可预测克罗恩病患者接受英夫利昔单抗维持治疗的长期疗效。
Inflamm Bowel Dis. 2009 Sep;15(9):1295-301. doi: 10.1002/ibd.20927.